Market closed
Puretech Health/£PRTC
08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX
About Puretech Health
PureTech Health, trading under the ticker PRTC, is a biotechnology company focused on discovering, developing, and commercializing highly differentiated medicines for devastating diseases. Operating within the healthcare sector, the company leverages its deep expertise in the understanding of disease physiology to advance a pipeline of novel therapies addressing serious medical conditions. Founded in 2015, PureTech Health engages in groundbreaking translational research that bridges the gap between innovative biological insights and potential impactful therapies.
Ticker
£PRTC
Sector
Trading on
LSE
Industry
Biotechnology
Headquarters
Employees
90
Website
Puretech Health Metrics
BasicAdvanced
£401M
Market cap
-
P/E ratio
-£0.24
EPS
1.00
Beta
-
Dividend rate
Price and volume
Market cap
£401M
Beta
1
52-week high
£2.39
52-week low
£1.39
Average daily volume
700K
Financial strength
Current ratio
3.679
Quick ratio
3.633
Long term debt to equity
43.722
Total debt to equity
47.267
Interest coverage (TTM)
-6.80%
Management effectiveness
Return on assets (TTM)
-13.39%
Return on equity (TTM)
-22.07%
Valuation
Price to revenue (TTM)
1,251.658
Price to book
1.27
Price to tangible book (TTM)
1.27
Price to free cash flow (TTM)
-4.841
Growth
Revenue change (TTM)
-96.01%
Earnings per share change (TTM)
78.63%
3-year revenue growth (CAGR)
-64.83%
3-year earnings per share growth (CAGR)
-23.47%
What the Analysts think about Puretech Health
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Puretech Health stock.
Puretech Health Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Puretech Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
FAQs
What’s the current market cap for Puretech Health stock?
Puretech Health (PRTC) has a market cap of £401M as of December 13, 2024.
What is the P/E ratio for Puretech Health stock?
The price to earnings (P/E) ratio for Puretech Health (PRTC) stock is 0 as of December 13, 2024.
Does Puretech Health stock pay dividends?
No, Puretech Health (PRTC) stock does not pay dividends to its shareholders as of December 13, 2024.
When is the next Puretech Health dividend payment date?
Puretech Health (PRTC) stock does not pay dividends to its shareholders.
What is the beta indicator for Puretech Health?
Puretech Health (PRTC) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.